Patent · US Active

RNA interference suppression of neurodegenerative diseases and methods of use thereof

US9260716B2 · kind B2 · utility

22Cited by
41References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 18, 2013
Grant dateFeb 16, 2016
Priority date
Expiry dateJun 18, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to small interfering RNA molecules (siRNA) targeted against nucleic acid sequence that encodes huntingtin or ataxin-1, and methods of using these siRNA molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.